Citations (105)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Catalin Adrian Buzea, Lorena Dima, Christoph U. Correll & Peter Manu. (2022) Drug–drug interactions involving antipsychotics and antihypertensives. Expert Opinion on Drug Metabolism & Toxicology 18:4, pages 285-298.
Read now
Read now
Atul Pathak & Sanaa Mrabeti. (2021) β-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now?. Vascular Health and Risk Management 17, pages 337-348.
Read now
Read now
Kazunori Shimada, Katsumi Miyauchi & Hiroyuki Daida. (2015) Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders. Expert Review of Cardiovascular Therapy 13:1, pages 23-31.
Read now
Read now
Harjinder Kaur, Kully Sandhu, Awais Jabbar & Azfar G Zaman. (2014) Optimal treatment of chronic angina in patients with type 2 diabetes mellitus. Research Reports in Clinical Cardiology 5, pages 155-167.
Read now
Read now
Gastone Leonetti & Colin G Egan. (2012) Use of carvedilol in hypertension: an update. Vascular Health and Risk Management 8, pages 307-322.
Read now
Read now
James J DiNicolantonio & Daniel G Hackam. (2012) Carvedilol: a third-generation β-blocker should be a first-choice β-blocker. Expert Review of Cardiovascular Therapy 10:1, pages 13-25.
Read now
Read now
Jeffrey S Freeman & Benjamin Gross. (2012) Potential drug interactions associated with treatments for Type 2 diabetes and its comorbidities: a clinical pharmacology review. Expert Review of Clinical Pharmacology 5:1, pages 31-42.
Read now
Read now
Hector Ventura, Ileana L. Piña & Carl J. Lavie. (2011) Hypertension and Antihypertensive Therapy in Hispanics and Mexican Americans Living in the United States. Postgraduate Medicine 123:6, pages 46-57.
Read now
Read now
B. Tomlinson, J.J. Dalal, J. Huang, L.P. Low, C.G. Park, A.R. Rahman, E.B. Reyes, A.A. Soenarta, A. Heagerty & F. Follath. (2011) The role of -blockers in the management of hypertension: An Asian perspective. Current Medical Research and Opinion 27:5, pages 1021-1033.
Read now
Read now
Articles from other publishers (96)
Madasamy Sundar & Krishnasamy Lingakumar. (2023) Investigating the efficacy of topical application of Ipomoea carnea herbal cream in preventing skin damage induced by UVB radiation in a rat model. Heliyon 9:9, pages e19161.
Crossref
Crossref
Priscila Akemi Yamamoto, Rodrigo Cristofoletti, Valvanera Vozmediano, Cristiane Masetto de Gaitani, Rodrigo Moreira da Silva, Rafael Kemp, Ajith Kumar Sankarankutty, Wilson Salgado Junior, Jose Sebastião dos Santos & Natalia Valadares de Moraes. (2023)
Effect of Roux‐En‐Y Gastric Bypass in the Pharmacokinetics of (
R
)‐Carvedilol and (
S
)‐Carvedilol
. The Journal of Clinical Pharmacology.
Crossref
Crossref
Ya-Wen Kuo, Jiann-Der Lee, Chuan-Pin Lee, Yen-Chu Huang & Meng Lee. (2023) Association between initial in-hospital heart rate and glycemic control in patients with acute ischemic stroke and diabetes mellitus. BMC Endocrine Disorders 23:1.
Crossref
Crossref
Kana Kubota, Kei Inai, Eriko Shimada & Tokuko Shinohara. (2023) α/β- and β-Blocker Exposure in Pregnancy and the Risk of Neonatal Hypoglycemia and Small for Gestational Age. Circulation Journal 87:4, pages 569-577.
Crossref
Crossref
Lina S. Farhoumand, Hongtao Liu, Theodora Tsimpaki, Ulrike B. Hendgen-Cotta, Tienush Rassaf, Nikolaos E. Bechrakis, Miltiadis Fiorentzis & Utta Berchner-Pfannschmidt. (2023) Blockade of ß-Adrenergic Receptors by Nebivolol Enables Tumor Control Potential for Uveal Melanoma in 3D Tumor Spheroids and 2D Cultures. International Journal of Molecular Sciences 24:6, pages 5894.
Crossref
Crossref
Simon Wernhart, Maria Papathanasiou, Tienush Rassaf & Peter Luedike. (2023) The controversial role of beta-blockers in heart failure with preserved ejection fraction. Pharmacology & Therapeutics 243, pages 108356.
Crossref
Crossref
Tiantong Feng, Wen Zhang, Xiaoxue Hou, Hui Yuan, Jinyuan Cai, Zhengyi Jiang, Pingping Hu, Ming Yue, Wenting Li, Chuanlong Zhu & Yuwen Li. (2023) Clinical significance of dynamic variation of low cholesterol and its prognostic value in patients with pyogenic liver abscesses: a retrospective study. BMC Infectious Diseases 23:1.
Crossref
Crossref
Ying Song, Anthony Yiu-Ho WOO, Yan Zhang & Ruiping Xiao. (2022) Cardiac β-Adrenoceptor Signaling: The New Insight on An Old Target in the Therapy of Cardiovascular Disease. International Journal of Drug Discovery and Pharmacology, pages 3.
Crossref
Crossref
Clayton L. Cruthirds, Nicolaas E. P. Deutz, Yani G. G. Mizubuti, Rajesh I. Harrykissoon, Anthony J. Zachria & Mariëlle P. K. J. Engelen. (2022) Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes. Nutrition & Metabolism 19:1.
Crossref
Crossref
Emma Ivantsova, Isaac Konig, Christopher L. SoudersIIII, David McNabney, Denina D.B. Simmons & Christopher J. Martyniuk. (2022) Lipidomic, metabolomic, and behavior responses of zebrafish (Danio rerio) exposed to environmental levels of the beta blocker atenolol. Science of The Total Environment, pages 161272.
Crossref
Crossref
Waleed AlHabeeb, Sanaa Mrabeti & Ahmed Adel Ibrahim Abdelsalam. (2021) Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease. Cardiovascular Drugs and Therapy 36:5, pages 959-971.
Crossref
Crossref
Chan Joo Lee, Jung-Hoon Sung, Tae-Soo Kang, Sungha Park, Sang-Hak Lee, Jong-Youn KimByeong-Kuek Kim. (2022) Effects of high-intensity statin combined with telmisartan versus amlodipine on glucose metabolism in hypertensive atherosclerotic cardiovascular disease patients with impaired fasting glucose: A randomized multicenter trial. Medicine 101:36, pages e30496.
Crossref
Crossref
Asim Ahmed Elnour Ahmed. (2022) Perspective on the Role of Four Beta-blockers in Heart Failure. Current Reviews in Clinical and Experimental Pharmacology 17:2, pages 85-89.
Crossref
Crossref
He-Yun Cheng, Hsiu C. Lin, Hsiu L. Lin, Yow S. Uang, Joseph J. Keller & Li H. Wang. (2022) Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation. Frontiers in Pharmacology 12.
Crossref
Crossref
Jiesuck Park, Jung-Kyu Han, Jeehoon Kang, In-Ho Chae, Sung Yun Lee, Young Jin Choi, Jay Young Rhew, Seung-Woon Rha, Eun-Seok Shin, Seong-Ill Woo, Han Cheol Lee, Kook-Jin Chun, DooIl Kim, Jin-Ok Jeong, Jang-Whan Bae, Han-Mo Yang, Kyung Woo Park, Hyun-Jae Kang, Bon-Kwon Koo & Hyo-Soo Kim. (2022) The Clinical Impact of β-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention. Korean Circulation Journal 52:7, pages 544.
Crossref
Crossref
Paul Valensi. (2021) Autonomic nervous system activity changes in patients with hypertension and overweight: role and therapeutic implications. Cardiovascular Diabetology 20:1.
Crossref
Crossref
RANJODH JEET SINGH. (2021) ANTIHYPERTENSIVE PHARMACOTHERAPY IN HYPERTENSIVE PATIENTS AT A TERTIARY CARE TEACHING HOSPITAL AND MEDICAL COLLEGE IN INDIA. Asian Journal of Pharmaceutical and Clinical Research, pages 30-36.
Crossref
Crossref
Zhen Li, Siyang Wang, Jian Ren, Tingting Zhi, Hongxia Wang, Yuanyuan Zhu, Yanhui Wang, Zhiqing Yao, Huizi Zhang, Jinxin Feng & Ruiqing Zhang. (2021) Analysis of Medication Prescriptions for Hypertension in a Class 1 and Grade A Hospital in Shanxi Province. Advances in Therapy 38:10, pages 5100-5115.
Crossref
Crossref
Carla Carnovale, Michele Gringeri, Vera Battini, Giulia Mosini, Elena Invernizzi, Faizan Mazhar, Francesco Bergamaschi, Mara Fumagalli, Gianvincenzo Zuccotti, Emilio Clementi, Sonia Radice & Valentina Fabiano. (2021) Beta‐blocker‐associated hypoglycaemia: New insights from a real‐world pharmacovigilance study. British Journal of Clinical Pharmacology 87:8, pages 3320-3331.
Crossref
Crossref
William Todd Cade, Richard Laforest, Kathryn L. Bohnert, Dominic N. Reeds, Adam J. Bittel, Lisa de las Fuentes, Adil Bashir, Pamela K. Woodard, Christina A. Pacak, Barry J. Byrne, Robert J. Gropler & Linda R. Peterson. (2019) Myocardial glucose and fatty acid metabolism is altered and associated with lower cardiac function in young adults with Barth syndrome. Journal of Nuclear Cardiology 28:4, pages 1649-1659.
Crossref
Crossref
Dianne M. Perez. (2021) Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure. International Journal of Molecular Sciences 22:11, pages 5783.
Crossref
Crossref
Silviu Constantin Badoiu, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Alexandra Ripszky Totan, Silvia Elena Badoiu, Michel Costagliola & Maria Greabu. (2021) Glucose Metabolism in Burns—What Happens?. International Journal of Molecular Sciences 22:10, pages 5159.
Crossref
Crossref
David S.H. Bell & Edison Goncalves. (2021) Diabetogenic effects of cardioprotective drugs. Diabetes, Obesity and Metabolism 23:4, pages 877-885.
Crossref
Crossref
Jaehoon Chung, Jung-Kyu Han, Han-Mo Yang, Kyung-Woo Park, Hyun-Jae Kang, Bon-Kwon Koo, Myung Ho Jeong & Hyo-Soo Kim. (2021) Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry. The Korean Journal of Internal Medicine 36:Suppl 1, pages S62-S71.
Crossref
Crossref
Ann A. Verhaegen & Luc F. Van Gaal. (2021) Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function—Mechanisms and Possible Therapeutic or Preventive Measures: an Update. Current Obesity Reports 10:1, pages 1-13.
Crossref
Crossref
Arruje Hameed, Tahir Farooq & Sadia Shabbir. 2021. Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies. Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies
357
365
.
Tomoyuki Saito, Hirotoshi Ohmura, Shuko Nojiri & Hiroyuki Daida. (2020) Impact of sitagliptin combination therapy and hypoglycemia in Japanese patients with type 2 diabetes: a multi-center retrospective observational cohort study. Journal of Pharmaceutical Health Care and Sciences 6:1.
Crossref
Crossref
Fotini Tsofliou, Yannis P Pitsiladis, Jose Lara, Marios Hadjicharalambous, Ian A Macdonald, Mike A Wallace & Mike E J Lean. (2020) The effects of moderate alterations in adrenergic activity on acute appetite regulation in obese women: A randomised crossover trial. Nutrition and Health 26:4, pages 311-322.
Crossref
Crossref
Sharmila P Bhanu, Suneetha Pentyala & Devi K Sankar. (2020) Incidence of hypoplastic posterior communicating artery and fetal posterior cerebral artery in Andhra population of India: a retrospective 3-Tesla magnetic resonance angiographic study. Anatomy & Cell Biology 53:3, pages 272-278.
Crossref
Crossref
Samaa Samir Kamar, Noha Samir Abdel Latif, Mohamed Fathi Mohamed Elrefai & Shaimaa Nasr Amin. (2020) Gastroprotective effects of nebivolol and simvastatin against cold restraint stress-induced gastric ulcer in rats. Anatomy & Cell Biology 53:3, pages 301-312.
Crossref
Crossref
Michel Marre. (2020) Importance of intensive blood pressure control in type 2 diabetes: Mechanisms, treatments and current guidelines. Diabetes, Obesity and Metabolism 22:S2, pages 33-42.
Crossref
Crossref
Alexandra Katsimardou, Konstantinos Imprialos, Konstantinos Stavropoulos, Alexandros Sachinidis, Michalis Doumas & Vasilios Athyros. (2020) Hypertension in Metabolic Syndrome: Novel Insights. Current Hypertension Reviews 16:1, pages 12-18.
Crossref
Crossref
Boris Mravec & Miroslav Tibensky. (2020) Increased cancer risk in polycystic ovary syndrome: An (un)sympathetic connection?. Medical Hypotheses 134, pages 109437.
Crossref
Crossref
Michal Vrablík & Eva Tůmová. (2019) Atherosclerosis and beta-blockade: A forgotten option?. Vnitřní lékařství 65:12, pages 795-801.
Crossref
Crossref
Eduardo Oliver, Federico Mayor Jr & Pilar D’Ocon. (2019) Bloqueadores beta: perspectiva histórica y mecanismos de acción. Revista Española de Cardiología 72:10, pages 853-862.
Crossref
Crossref
Eduardo Oliver, Federico Mayor Jr & Pilar D’Ocon. (2019) Beta-blockers: Historical Perspective and Mechanisms of Action. Revista Española de Cardiología (English Edition) 72:10, pages 853-862.
Crossref
Crossref
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, Larry A. Allen, Michael Chan, Akshay S. Desai, Anita Deswal, Victoria Vaughan Dickson, Mikhail N. Kosiborod, Carolyn L. Lekavich, Rozalina G. McCoy, Robert J. Mentz & Ileana L. Piña. (2019) Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation 140:7.
Crossref
Crossref
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, Larry A. Allen, Michael Chan, Akshay S. Desai, Anita Deswal, Victoria Vaughan Dickson, Mikhail N. Kosiborod, Carolyn L. Lekavich, Rozalina G. McCoy, Robert J. Mentz & Ileana L. PiÑa. (2019) Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. Journal of Cardiac Failure 25:8, pages 584-619.
Crossref
Crossref
William Todd Cade, Kathryn L. Bohnert, Linda R. Peterson, Bruce W. Patterson, Adam J. Bittel, Adewole L. Okunade, Lisa de las Fuentes, Karen Steger‐May, Adil Bashir, George G. Schweitzer, Shaji K. Chacko, Ronald J. Wanders, Christina A. Pacak, Barry J. Byrne & Dominic N. Reeds. (2019) Blunted fat oxidation upon submaximal exercise is partially compensated by enhanced glucose metabolism in children, adolescents, and young adults with Barth syndrome. Journal of Inherited Metabolic Disease 42:3, pages 480-493.
Crossref
Crossref
Ahmad Abdulrahman Almeman, Yasir Ahmed Beshir & Ahmad Hamad Aldosary. (2019) Comparison of the Effects of Metoprolol and Bisoprolol on Lipid and Glucose Profiles in Cardiovascular Patients. Current Drug Safety 14:1, pages 27-30.
Crossref
Crossref
B. Vergès. (2019) Les médicaments cardiovasculaires qui favorisent le diabète. Archives des Maladies du Coeur et des Vaisseaux - Pratique 2019:274, pages 20-23.
Crossref
Crossref
Nikolaos Magkas, Athanasia Kapota & Costas Tsioufis. 2019. Management of Hypertension. Management of Hypertension
155
182
.
Jonathan Owen, Stephen Morse, Angela McLean & Efrain Reisin. 2019. Prehypertension and Cardiometabolic Syndrome. Prehypertension and Cardiometabolic Syndrome
197
229
.
Linda A. Morrow & Andrew J. Krentz. 2019. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease
517
538
.
Brent Egan, John Flack, Mehul Patel & Sofia Lombera. (2018) Insights on β-blockers for the treatment of hypertension: A survey of health care practitioners. The Journal of Clinical Hypertension 20:10, pages 1464-1472.
Crossref
Crossref
Anthony L. Gonzalez & Deborah C. Silverstein. 2018. Textbook of Small Animal Emergency Medicine. Textbook of Small Animal Emergency Medicine
719
725
.
Yana Anfinogenova, Elena V. Grakova, Maria Shvedova, Kristina V. Kopieva, Alexander T. Teplyakov & Sergey V. Popov. (2017) Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure. Heart Failure Reviews 23:3, pages 481-497.
Crossref
Crossref
Siree Kaempfen, Roland P Neumann, Kerstin Jost & Sven M Schulzke. (2018) Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants. Cochrane Database of Systematic Reviews 2018:3.
Crossref
Crossref
Aline Alexandra Iannoni de Moraes, Antonio Carlos Palandri Chagas, José Rocha Faria Neto & Protásio Lemos da Luz. 2018. Endothelium and Cardiovascular Diseases. Endothelium and Cardiovascular Diseases
455
472
.
Jaehoon Chung, Jung‐Kyu Han, Young Jo Kim, Chong Jin Kim, Youngkeun Ahn, Myeong Chan Cho, Shung Chull Chae, In‐Ho Chae, Jei Keon Chae, In‐Whan Seong, Han‐Mo Yang, Kyung‐Woo Park, Hyun‐Jae Kang, Bon‐Kwon Koo, Myung Ho Jeong, Hyo‐Soo Kim, Tae Hoon Ahn, Kwang Soo Cha, Hyeon‐Cheol Gwon, Jin‐Yong Hwang, Seung Jae Joo, Doo‐il Kim, Kwon‐Bae Kim, Dong Joo Oh, Seok Kyu Oh, Ki‐Bae Seung & Jung‐Han Yoon. (2017) Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study. Journal of the American Heart Association 6:10.
Crossref
Crossref
Christian W. Mende, Thomas D. Giles, David B. Bharucha, William G. Ferguson, Madhuja Mallick & Mehul D. Patel. (2017) Efficacy of nebivolol-valsartan single-pill combination in obese and nonobese patients with hypertension. The Journal of Clinical Hypertension 19:6, pages 632-639.
Crossref
Crossref
Hamish CG Prosser, Cynthia Gregory, Dagmara Hering, Graham S Hillis, Greg Perry, Johan Rosman, Carl Schultz, Mark Thomas, Gerald F Watts & Markus P Schlaich. (2017) Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?. Current Hypertension Reports 19:4.
Crossref
Crossref
Jason E. Allen, Stacey Knight, Raymond O. McCubrey, Tami Bair, Joseph Brent Muhlestein, Jeffrey J. Goldberger & Jeffrey L. Anderson. (2017) β-blocker dosage and outcomes after acute coronary syndrome. American Heart Journal 184, pages 26-36.
Crossref
Crossref
Paula Aver Bretanha Ribeiro, Eve Normandin, Philippe Meyer, Martin Juneau, Anil Nigam & Mathieu Gayda. (2017) Comparison of Carbohydrate and Lipid Oxidation During Different High-Intensity Interval Exercise in Patients with Chronic Heart Failure. American Journal of Physical Medicine & Rehabilitation 96:1, pages 50-54.
Crossref
Crossref
Christian Höcht, Facundo Martín Bertera, Julieta Sofía Del Mauro, Luciano Parola & Carlos Alberto Taira. (2016) PK/PD modeling of β-blockers in cardiovascular disease: an update. International Journal of Pharmacokinetics 1:1, pages 55-68.
Crossref
Crossref
Tülün Öztürk, Kamil Vural, İbrahim Tuğlu, Ahmet Var, Taner Kurdal & Işıl Aydemir. (2016) Acute and Chronic Pretreatment With Atenolol Attenuates Intestinal Ischemia and Reperfusion Injury in Hypercholesterolemic Rats. Journal of Cardiothoracic and Vascular Anesthesia 30:4, pages 985-992.
Crossref
Crossref
Sheng-Hua Yang, Ying Du, Sha Li, Yan Zhang, Rui-Xia Xu, Cheng-Gang Zhu, Yuan-Lin Guo, Na-Qiong Wu, Qian Dong, Jing Sun & Jian-Jun Li. (2016) Plasma PCSK9 level is unrelated to blood pressure and not associated independently with carotid intima–media thickness in hypertensives. Hypertension Research 39:8, pages 598-605.
Crossref
Crossref
Ronan T. Grimes, Jane Ensor, Kathleen Bennett & Martin C. Henman. (2016) Use of cardiovascular medicines in newly treated type 2 diabetes patients: A retrospective cohort study in general practice. Primary Care Diabetes 10:4, pages 237-243.
Crossref
Crossref
Fateme Shamekhi Amiri. (2016) Recent advances in the treatment of renal diseases with nebivolol: A literature review. Néphrologie & Thérapeutique 12:3, pages 140-148.
Crossref
Crossref
Pyung Chun Oh, Woong Chol Kang, Jeonggeun Moon, Yae Min Park, Sihun Kim, Myeong Gun Kim, Kyounghoon Lee, Taehoon Ahn & Eak Kyun Shin. (2016) Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study. American Journal of Cardiovascular Drugs 16:3, pages 221-228.
Crossref
Crossref
Sherief R. Janmohamed, Nisha Suyien Chandran & Arnold P. Oranje. 2016. Practical Pediatric Dermatology. Practical Pediatric Dermatology
69
78
.
Siree Kaempfen, Roland P Neumann, Kerstin Jost & Sven M Schulzke. (2015) Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Joseph Vamecq, Karine Mention-Mulliez, Francis Leclerc & Dries Dobbelaere. (2015) Opioid Facilitation of β-Adrenergic Blockade: A New Pharmacological Condition?. Pharmaceuticals 8:4, pages 664-674.
Crossref
Crossref
Jeffrey J. Goldberger, Robert O. Bonow, Michael Cuffe, Lei Liu, Yves Rosenberg, Prediman K. Shah, Sidney C. SmithJr.Jr. & Haris Subačius. (2015) Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction. Journal of the American College of Cardiology 66:13, pages 1431-1441.
Crossref
Crossref
Justin Fongemie & Erika Felix-Getzik. (2015) A Review of Nebivolol Pharmacology and Clinical Evidence. Drugs 75:12, pages 1349-1371.
Crossref
Crossref
David Ho, Xin Zhao, Lin Yan, Chujun Yuan, Haihong Zong, Dorothy E. Vatner, Jeffery E. Pessin & Stephen F. Vatner. (2015) Adenylyl Cyclase Type 5 Deficiency Protects Against Diet-Induced Obesity and Insulin Resistance. Diabetes 64:7, pages 2636-2645.
Crossref
Crossref
Joanna C. Murrell. 2015. Veterinary Anesthesia and Analgesia. Veterinary Anesthesia and Analgesia
183
195
.
D. Dobbelaere, F. Leclerc, K. Mention-Mulliez & J. Vamecq. (2015) Propranolol et lactatémie durant un choc hypovolémique non septique : à propos d’une observation. Archives de Pédiatrie 22:3, pages 292-295.
Crossref
Crossref
Santanu Rana, Kaberi Datta, Teegala Lakshminarayan Reddy, Emeli Chatterjee, Preeta Sen, Manika Pal-Bhadra, Utpal Bhadra, Arindam Pramanik, Panchanan Pramanik, Mamta Chawla-Sarkar & Sagartirtha Sarkar. (2015) A spatio-temporal cardiomyocyte targeted vector system for efficient delivery of therapeutic payloads to regress cardiac hypertrophy abating bystander effect. Journal of Controlled Release 200, pages 167-178.
Crossref
Crossref
Linda A. Morrow & Andrew J. Krentz. 2015. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development
225
242
.
A. H. Mulder, P. Smits & C. J. Tack. (2014) Beta2-adrenoceptor stimulation has no effect on skeletal muscle glucose uptake. Clinical Autonomic Research 24:4, pages 183-187.
Crossref
Crossref
Jakub Toczek, Alexis Broisat, Pascale Perret, Marie-Dominique Desruet, Daniel Fagret, Laurent M. Riou & Catherine Ghezzi. (2014) Periaortic Brown Adipose Tissue as a Major Determinant of [18F]-Fluorodeoxyglucose Vascular Uptake in Atherosclerosis-Prone, ApoE−/− Mice. PLoS ONE 9:7, pages e99441.
Crossref
Crossref
. (2014) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary. Diabetes and Vascular Disease Research 11:3, pages 133-173.
Crossref
Crossref
Lars Rydén, Peter J. Grant, Stefan D. Anker, Christian Berne, Francesco Cosentino, Nicolas Danchin, Christi Deaton, Javier Escaned, Hans-Peter Hammes, Heikki Huikuri, Michel Marre, Nikolaus Marx, Linda Mellbin, Jan Ostergren, Carlo Patrono, Petar Seferovic, Miguel Sousa Uva, Marja-Riita Taskinen, Michal Tendera, Jaakko Tuomilehto, Paul Valensi, José Luis Zamorano, Jose Luis Zamorano, Stephan Achenbach, Helmut Baumgartner, Jeroen J. Bax, Héctor Bueno, Veronica Dean, Christi Deaton, Çetin Erol, Robert Fagard, Roberto Ferrari, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Patrizio Lancellotti, Ales Linhart, Petros Nihoyannopoulos, Massimo F. Piepoli, Piotr Ponikowski, Per Anton Sirnes, Juan Luis Tamargo, Michal Tendera, Adam Torbicki, William Wijns, Stephan Windecker, Guy De Backer, Per Anton Sirnes, Eduardo Alegria Ezquerra, Angelo Avogaro, Lina Badimon, Elena Baranova, Helmut Baumgartner, John Betteridge, Antonio Ceriello, Robert Fagard, Christian Funck-Brentano, Dietrich C. Gulba, David Hasdai, Arno W. Hoes, John K. Kjekshus, Juhani Knuuti, Philippe Kolh, Eli Lev, Christian Mueller, Ludwig Neyses, Peter M. Nilsson, Joep Perk, Piotr Ponikowski, Željko Reiner, Naveed Sattar, Volker Schächinger, André Scheen, Henrik Schirmer, Anna Strömberg, Svetlana Sudzhaeva, Juan Luis Tamargo, Margus Viigimaa, Charalambos Vlachopoulos & Robert G. Xuereb. (2014) Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes. Revista Española de Cardiología 67:2, pages 136.e1-136.e56.
Crossref
Crossref
Hae-Young Lee, Ichiro Sakuma, Sang-Hyun Ihm, Choong-Won Goh & Kwang Kon Koh. (2014) Statins and Renin-Angiotensin System Inhibitor Combination Treatment to Prevent Cardiovascular Disease. Circulation Journal 78:2, pages 281-287.
Crossref
Crossref
Monika Kubacka, Szczepan Mogilski, Marek Bednarski, Katarzyna Raźny, Jacek Sapa, Anna Maria Waszkielewicz, Henryk Marona & Barbara Filipek. (2014) The Nitric Oxide/Soluble Cyclic Guanylase/Cyclic Guanosine Monophosphate Pathway Is Involved in the Cardiovascular Effects of a Novel α<sub>1</sub>- and β-Adrenoceptor Antagonist. Pharmacology 94:5-6, pages 287-295.
Crossref
Crossref
. (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal 34:39, pages 3035-3087.
Crossref
Crossref
Thomas D. Giles, Bobby V. Khan, June Lato, Lillian Brener, Yimin Ma & Tatjana Lukic. (2013) Nebivolol Monotherapy in Younger Adults (Younger Than 55 Years) With Hypertension: A Randomized, Placebo-Controlled Trial. The Journal of Clinical Hypertension 15:9, pages 687-693.
Crossref
Crossref
Marina Picillo, Roberto Erro, Gabriella Santangelo, Rosario Pivonello, Katia Longo, Claudia Pivonello, Carmine Vitale, Marianna Amboni, Marcello Moccia, Annamaria Colao, Paolo Barone & Maria Teresa Pellecchia. (2013) Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease. Journal of Neurology 260:7, pages 1724-1730.
Crossref
Crossref
Cynthia F.F. Santos, Sérgio H.S. Santos, Adaliene V.M. Ferreira, Leida M. Botion, Robson A.S. Santos & Maria Jose Campagnole-Santos. (2013) Association of an oral formulation of angiotensin-(1–7) with atenolol improves lipid metabolism in hypertensive rats. Peptides 43, pages 155-159.
Crossref
Crossref
Prakash Deedwania, John Shea, Wei Chen & Lillian Brener. (2013) Effects of Add‐On Nebivolol on Blood Pressure and Glucose Parameters in Hypertensive Patients With Prediabetes. The Journal of Clinical Hypertension 15:4, pages 270-278.
Crossref
Crossref
Paul M Vanhoutte & Yuansheng Gao. (2013) Beta blockers, nitric oxide, and cardiovascular disease. Current Opinion in Pharmacology 13:2, pages 265-273.
Crossref
Crossref
H. N. Boyda, R. M. Procyshyn, C. C. Y. Pang & A. M. Barr. (2013) Peripheral Adrenoceptors: The Impetus Behind Glucose Dysregulation and Insulin Resistance. Journal of Neuroendocrinology 25:3, pages 217-228.
Crossref
Crossref
Eberhard Standl, Michael Erbach & Oliver Schnell. (2012) What should be the antihypertensive drug of choice in diabetic patients and should we avoid drugs that increase glucose levels? Pro and Cons. Diabetes/Metabolism Research and Reviews 28:s2, pages 60-66.
Crossref
Crossref
F. Wilford Germino, Yuhua Lin, Vojislav Pejović & Lynn Bowen. (2012) Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I–II hypertension. Therapeutic Advances in Cardiovascular Disease 6:5, pages 185-199.
Crossref
Crossref
Mohamed A. Morsy, Gehan H. Heeba, Soha A. Abdelwahab & Remon R. Rofaeil. (2012) Protective effects of nebivolol against cold restraint stress-induced gastric ulcer in rats: Role of NO, HO-1, and COX-1,2. Nitric Oxide 27:2, pages 117-122.
Crossref
Crossref
Francisco Lopez-Jimenez, Valerie Carroll Kramer, Barbara Masters, Patricia (Mickey) W. Stuart, Cathy Mullooly, Ling Hinshaw, Linda Haas & Kathy Warwick. (2012) Recommendations for Managing Patients With Diabetes Mellitus in Cardiopulmonary Rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention 32:2, pages 101-112.
Crossref
Crossref
Mary M. StephensBeth A. FoxLisa Maxwell. (2012) Therapeutic Options for the Treatment of Hypertension in Children and Adolescents. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 6, pages CCRPM.S7602.
Crossref
Crossref
Peter M. Nilsson. 2012. Special Issues in Hypertension. Special Issues in Hypertension
133
146
.
S.R. Janmohamed, P.C.J. de Laat, G.C. Madern & A.P. Oranje. (2011) Do we have to check glucose in patients with haemangioma of infancy treated with beta-blockers?. Journal of the European Academy of Dermatology and Venereology 25:12, pages 4190-4190.
Crossref
Crossref
Julie BlattDean S. Morrell, Scott Buck, Carlton Zdanski, Stuart Gold, Joseph Stavas, Cynthia Powell & Craig N. Burkhart. (2011) β-Blockers for Infantile Hemangiomas: A Single-Institution Experience. Clinical Pediatrics 50:8, pages 757-763.
Crossref
Crossref
Anna‐Lena Hård & Ann Hellström. (2011) On the use of antiangiogenetic medications for retinopathy of prematurity. Acta Paediatrica 100:8, pages 1063-1065.
Crossref
Crossref
Claudio Ponticelli, David Cucchiari & Giorgio Graziani. (2011) Hypertension in kidney transplant recipients. Transplant International 24:6, pages 523-533.
Crossref
Crossref
Henry PunziAndrew Lewin, Tatjana Lukić, Thomas Goodin & Wei Chen. (2010) Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial. Therapeutic Advances in Cardiovascular Disease 4:6, pages 349-357.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Anaesthesiology 23:6, pages 778-783.
Crossref
Crossref
Leonardo Calò, Marco Rebecchi, Antonella Sette, Annamaria Martino, Ermenegildo de Ruvo, Luigi Sciarra, Lucia De Luca, Lorenzo Maria Zuccaro, Giuseppe Giunta, Antonio Ciccaglioni, Ernesto Lioy & Francesco Fedele. (2010) Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm 7:9, pages 1318-1323.
Crossref
Crossref